NEDAMSS patients and scientists meet
Families, researchers, and clinicians will gather in Berlin to share knowledge and build momentum toward therapies for NEDAMSS, a rare neurodevelopmental disorder. Jakob Metzger, Group Leader of the Quantitative Stem Cell Biology lab explains why this day matters and what participants can expect.